April 17, 2012 11:57 ET

Arena Pharmaceuticals Inc. (ARNA) Drops. After Months of Rising Steadily, the Stock Now Appears to Be Heading in the Wrong Direction

LAS VEGAS, NEVADA--(Marketwire - April 17, 2012) - At RocketAlerts we specialize in spotting reliable penny stocks capable of skyrocketing the investment of the quick thinking investor and we've been tracking Arena Pharmaceuticals Inc. (ARNA) right from the start. The stock has been rising steadily for months and has been one of the most reliable ones around. In recent days this steady rocket seemed to be stalling and today it has experienced a major loss of altitude. Investors now face a stark choice, cut losses and sell or bet that this is a temporary event and stick with it. As always you have to look at the risk-reward ratio to make a decision. What do the numbers say?

The key to a successful investment strategy is having the ability to pick the correct entry and exit points. With our approach you will get not only be able to get in early enough to profit from the rise but you will also learn what signs to look for in order to have a safe and profitable exit strategy. Remember even hot stocks can crash. To see how you can boost your investment profits with our absolutely FREE Newsletter please visit our website:

At RocketAlerts we realize that most investors can succeed if they have the right tools in their investment belt. We also know that it's not just about getting into a particular stock that counts but also about getting out at the right time. At RocketAlerts we do the hard work and the complex technical analysis leaving you with plenty of time to plan your entry and exit points. With our pinpoint down range projections you will have all the tools you need to home-in on the kinds of gains you've only been dreaming about. To get our FREE newsletter please visit us at:

- Disclosure - is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. is a wholly owned entity of a financial public relations firm. Please read our report and visit our website,, for complete risks and disclosures.

Contact Information